Randomized Controlled, Double-blinded, Active-controlled designed clinical trial evaluating The effects of cranial electrotherapy stimulation(CES) in treatment anxiety and stress.

Hallym University Medical Center- Chuncheon0 个研究点目标入组 60 人开始时间: 待定最近更新: 2019年6月17日

试验速览

暂无简介。

•1) Participants with Anxiety, Stress-relate disorder self-report score higher then four.
•2) Men and women aged 19 to 65.
•3) Those who are able to read and understand subject explanations and agreements, and who have the language ability to respond to the questionnaire.
•4) Those who have voluntarily participated in the clinical trial and have agreed to the written consent of the subject and are able to participate in the entire period of the clinical trial.

•1) Except Anxiety disorder, according to the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) dignosed Axis I.
•2) Primary diagnosis of alcohol or substance abuse
•3) diagnosed with bipolar or psychotic major depressive disorder
•4) attempted suicide before 6 months of screening
•5) A person who is rated at 6 or more in suicidal tendency
•6) A person judged to have problems with electroencephalography (EEG) or Alternating Current (AC) stimulation electrodes due to deformity of the scalp, inflammation reaction or other dermatological problems.
•7) Have a contraindication about CES equipment(ex, A metal board is Inserted in the head).
•8) A history of epilepsy and family history
•9) Those with serious clinical impairment of cardiovascular, digestive, respiratory, endocrine, and central nervous system
•10) Those who participated in other clinical trials within 30 days from the screening date
•11) Female subjects likely to become pregnant
•12) Pregnant or lactating women
•13) In addition to the above, persons with clinical symptoms who are judged medically by the person in charge of testing or who are considered inappropriate for this test

发起方

Hallym University Medical Center- Chuncheon